Perchlorate

Perchlorate

SCHEMBL4886261

C[n+]1c(/C=C/c2c(O)ccc3ccccc23)ccc2ccccc21.[O-][Cl+3]([O-])([O-])[O-]

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 14/20 0.54
KMT2A Q03164 5/20 0.54
POLB P06746 4/20 0.54
BCHE P06276 6/20 0.46
MEN1 O00255 3/20 0.45
MAPT P10636 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
NPC1 O15118 1/20 0.45
LMNA P02545 1/20 0.45
THRB P10828 1/20 0.45
PKM P14618 1/20 0.45
MAPK1 P28482 1/20 0.45
HTT P42858 1/20 0.45
RECQL P46063 1/20 0.45
RAB9A P51151 1/20 0.45
BLM P54132 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
ERN1 O75460 1/20 0.43
RIOK2 Q9BVS4 1/20 0.42
KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Perchlorate SCHEMBL4886286 1.00 ACHE (0.54) ACHEKMT2APOLBBCHEMEN1
Perchlorate SCHEMBL4887854 0.84 MAPT (0.45) ACHEKMT2APOLBMEN1MAPT
Perchlorate SCHEMBL5267081 0.84 MAPT (0.45) ACHEKMT2APOLBMEN1MAPT
Perchlorate SCHEMBL4882609 0.80 ACHE (0.58) ACHEKMT2APOLBBCHEMEN1
Perchlorate SCHEMBL4882628 0.80 ACHE (0.58) ACHEKMT2APOLBBCHEMEN1
SCHEMBL4876073 0.80 KMT2A (0.49) ACHEKMT2APOLBBCHEMEN1
Perchlorate SCHEMBL4882254 0.79 KMT2A (0.44) KMT2APOLBMEN1MAPTSMN1; SMN2
Perchlorate SCHEMBL4882267 0.79 KMT2A (0.44) KMT2APOLBMEN1MAPTSMN1; SMN2
SCHEMBL7915285 0.75 ERN1 (0.70) KMT2APOLBMEN1MAPTSMN1; SMN2
SCHEMBL7915280 0.75 ERN1 (0.70) KMT2APOLBMEN1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080281105-A1 Novel Quinolinium Salts and Derivatives IMMUSOL INCORPORATED (US) 2008-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080281105-A1 Novel Quinolinium Salts and Derivatives NQO2, MCL1, KRAS ACHE 3641/4885KMT2A 944/4885POLB 1589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.